Ryuichi Morishita, MD, PhD, graduated Osaka University Medical School in 1987, and received PhD from Osaka University in 1991. After following postdoctoral Fellow at Stanford University School of Medicine, he served as an Assistant Professor, Department of Geriatric Medicine, Osaka University Medical School from 1994 to 1998. Then, from 1998 to 2003, he was Associate Professor, Division of Gene Therapy Science, Osaka University Medical School. Then, he became Professor & Chairman of Division of Clinical Gene Therapy, Graduate School of Medicine, Osaka University Medical School from 2003. Professor Morishita received over 20 awards from various academic societies including Harry Goldbratt Award in Council of High Blood Pressure, American Heart Association, Award in Japanese of Japan Medical Society, Sato Award in 27th annual meeting of the Japanese Circulation Society and Invitrogen-Nature-Biotechnology Award. Professor Morishita is currently on the editorial board of over 30 scientific journals including The Open Gene Therapy Journal (Editor-in-Chief), Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry (Editor-in-Chief), Gene Therapy, ATVB, Circulation, Hypertension, and Cardiovascular Research. He has published over 400 original articles and review papers, primarily on gene therapy and molecular biology in cardiovascular disease. In addition, Professor Morishita is a Board Member of numerous medical organizations, including Japanese Society of Gene Therapy, Japan Society of Vascular Medicine, Japanese Society of Anti-aging, Japan Society of Hypertension, and others. Currently, he is a member of Regulatory Affairs and also Strategic Adviser of Health Care & Medical Strategy in Abe Cabinet. He is also Special Strategic Adviser in Osaka City and Osaka Prefecture. Previously, he worked as a member of Intellectual Property Committee of Koizumi & Abe Cabinet. His professional activities & appointments include Committee for Industry-Academia Relationship, Ministry of Education, Science and Culture of Japan, Vice Chairman, Bio-Venture Association Originated from Universities, and others.